Genetic Testing Underutilized in Early Breast Cancer
Patients with early-stage breast cancer often undergo definitive surgery without genetic testing, or before BRCA1/2 testing has been performed, and the results frequently aren't explained to them, a survey of surgeons and patients found.
Approximately one-third of surgeons said they rarely referred patients for genetic counseling, and only 73% of high-volume surgeons and 35% of lower-volume surgeons said they were confident in discussing genetic test results with their patients, reported Allison Kurian, MD, of the Stanford University School of Medicine in California, and colleagues.
To read the full article, click HERE
Written by Jeff Minerd for MedPage Today